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analysis revealed the lower PS score, more organs metastasis, the serum CY-211 beyond the upper limit of normal were independent prognostic factors in NSCLC patients with wild-type EGFR, the risk of death increased respectively 2.589, 1.986, 3.546 (1/0.282) times (P¼0.041, P ¼0.006, P ¼0.007). 2 In the second-line treatment, 30 patients experienced the failure of platinum were divided into chemotherapy group and TKI group. The TKI group were elderly and had a bad PS. The two groups had no significant differences in ORR, OS, side effects(P>0.05); the mPFS of chemotherapy group extended 2.6 months compared with TKI group (P ¼0.004); DCR was also better than TKI group (P¼0.019). 3 The first-line TKI group had 14 patients, the mOS was 6 months and the mPFS was 2 months. The second-line TKI group including 10 patients, the mOS was 31 months and the mPFS was 3 months (P ¼0.008, P ¼0.009). The ORR, DCR and adverse reaction between two groups had no significant differences (P >0.05). 4 40 patients were detected with ALK gene, and fusion mutation was found in 2 patients. There were six patients detecting multiple genes, based on the wild EGFR gene, one patient had EML4-ALK fusion mutation, one had the EGFR A767_V769dup and PI3KCA mutation, one companied with HER-2 mutation, one had the RET, HDAC4, FLT4, NOTGH1, BTK mutations, and one was not associated with other genes variation. Conclusion: 1 Low PS, distant metastasis, serum CY-211 beyond the upper limit of normal were independent adverse prognostic factors in advanced NSCLC patients with wild-type EGFR. 2 There were no significant difference in OS and serious side effects between two groups; the chemotherapy group had a longer PFS and a better DCR. 3 The second-line TKI group had a better OS, PFS compared to the firstline TKI group. 4 EGFR wild-type patients may be combined with other genes variation including EML4-ALK, HER-2, PIK3CA and other mutations, providing an opportunity for precise medicine. Keyword: EGFR wild-type, NSCLC, Prognosis, TKI, Overall survival, Gene detection. Next generation sequencing (NGS) was used to detect the mutation status of lung cancer related driving gene. Results: 1 Relationship between the pathological subtype of lung adenocarcinoma and EGFR mutation: the most common pathological subtype in this study was acinar adenocarcinoma, followed by solid adenocarcinoma, then papillary adenocarcinoma, lepidic growth, and invasive mucinous adenocarcinoma. Acinar adenocarcinoma had the highest rate of EGFR mutation, followed by papillary adenocarcinoma, lepidic growth type adenocarcinoma, solid type. Invasive mucinous adenocarcinoma did not show EGFR mutation. Statistically significant differences in EGFR December 2018
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